A STUDY OF THE EFFECT OF VASOPRESSIN IN REDUCING BLOOD LOSS IN
GYNAECOLOGICAL SURGERIES
BACKGROUND: The use of vasopressin in major surgeries like hysterectomy and myomectomy can decrease the morbidity of the patient by controlling the intra-operative blood loss. MATERIAL AND METHODS: About 100 patients undergoing elective vaginal hysterectomy and myomectomy were selected for the study. They were divided into two groups, in case group vasopressin in diluted form was inltrated intraoperatively in the surgical eld and in control group no inltration was done. The two groups were compared in terms of intraoperative blood loss, mean post operative hemoglobin decrease, hospital stay and associated adverse outcome. Statistical analysis was performed using statistical package for social science (SPSS) for windows version 19.0 software Chicago, SPSS. RESULT CONCLUSION: Vasopressin is a drug which can play a key role in reducing post-operative morbidity in the patients undergoing major gynaecological operations (vaginal hysterectomy and myomectomy) by decreasing intraoperative blood loss. In the present study estimated intraoperative blood loss in vasopressin group was 145.27 ml which was signicantly low in comparison to no injection group in which was 266.45 ml (p value <0.05). This resulted in lesser fall in post-operative heamoglobin level and reduced blood transfusion requirement in vasopressin group. Parameters like duration of surgery, change in vitals during surgery and post-operative complications showed no signicant change in vasopressin group (P<0.0001).